Jerusalem, 22 January, 2026 (TPS-IL) — Israeli dietary supplement manufacturer TopGum Industries has signed a binding letter of intent to acquire U.S. operations specializing in pharmaceutical and dietary supplement gummies. The deal marks TopGum’s entry into the pharmaceutical domain and includes a U.S. facility with FDA-compliant production lines for pharmaceutical-grade gummies containing active pharmaceutical ingredients.
The acquisition combines cash and equity valued at up to $37 million, including contingent consideration.